{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:41:31Z","timestamp":1791481291970,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Juvenile Diabetes Research Foundation (JDRF)"},{"name":"Canadian Institute for Health Research (CIHR)"},{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association (CDA)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science Foundation China (NSFC)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.autrev.2015.07.011","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T16:36:23Z","timestamp":1438187783000},"page":"1048-1056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Immunological GABAergic interactions and therapeutic applications in autoimmune diseases"],"prefix":"10.1016","volume":"14","author":[{"given":"G\u00e9rald J.","family":"Prud'homme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Glinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.autrev.2015.07.011_bb0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2337\/diab.28.7.629","article-title":"High concentration of gamma-aminobutyric acid in pancreatic beta cells","volume":"28","author":"Taniguchi","year":"1979","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.autrev.2015.07.011_bb0010","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1073\/pnas.0915139107","article-title":"Inhibitory role for GABA in autoimmune inflammation","volume":"107","author":"Bhat","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.07.011_bb0015","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.173.8.5298","article-title":"Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model","volume":"173","author":"Tian","year":"2004","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2015.07.011_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2008.08.017","article-title":"GABA, a natural immunomodulator of T lymphocytes","volume":"205","author":"Bjurst\u00f6m","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.autrev.2015.07.011_bb0025","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.molimm.2005.07.025","article-title":"Human peripheral blood mononuclear cells express GABAA receptor subunits","volume":"43","author":"Alam","year":"2006","journal-title":"Mol Immunol"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2015.07.011_bb0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.neuropharm.2010.11.007","article-title":"An intrinsic GABAergic system in human lymphocytes","volume":"60","author":"Dionisio","year":"2011","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.autrev.2015.07.011_bb0035","doi-asserted-by":"crossref","first-page":"e42959","DOI":"10.1371\/journal.pone.0042959","article-title":"Different subtypes of GABA-A receptors are expressed in human, mouse and rat T lymphocytes","volume":"7","author":"Mendu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.011_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cmet.2005.11.015","article-title":"Intra-islet insulin suppresses glucagon release via GABA\u2013GABAA receptor system","volume":"3","author":"Xu","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2015.07.011_bb0045","first-page":"485","article-title":"Intra-islet glucagon secretion and action in the regulation of glucose homeostasis","volume":"3","author":"Wang","year":"2012","journal-title":"Front Physiol"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.011_bb0050","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2337\/db09-0797","article-title":"Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells","volume":"59","author":"Braun","year":"2010","journal-title":"Diabetes"},{"issue":"28","key":"10.1016\/j.autrev.2015.07.011_bb0055","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1073\/pnas.1102715108","article-title":"GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes","volume":"108","author":"Soltani","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.07.011_bb0060","first-page":"79","article-title":"GABAergic system in the endocrine pancreas: a new target for diabetes treatment","volume":"8","author":"Wan","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1\u20133","key":"10.1016\/j.autrev.2015.07.011_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuint.2009.01.020","article-title":"A novel mechanism for GABA synthesis and packaging into synaptic vesicles","volume":"55","author":"Buddhala","year":"2009","journal-title":"Neurochem Int"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.011_bb0070","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1074\/jbc.275.7.5188","article-title":"Alternative splicing of GAD67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other non-neural tissues","volume":"275","author":"Chessler","year":"2000","journal-title":"J Biol Chem"},{"issue":"5417","key":"10.1016\/j.autrev.2015.07.011_bb0075","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1126\/science.284.5417.1183","article-title":"Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells","volume":"284","author":"Yoon","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.011_bb0080","doi-asserted-by":"crossref","first-page":"247-6","DOI":"10.1016\/0300-9629(95)00099-2","article-title":"Gamma-aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues","volume":"112","author":"Tillakaratne","year":"1995","journal-title":"Comp Biochem Physiol A Physiol"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0300-9084(00)00221-2","article-title":"The loading of neurotransmitters into synaptic vesicles","volume":"82","author":"Gasnier","year":"2000","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.autrev.2015.07.011_bb0090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.autrev.2015.07.011_bb0095","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/jm9904349","article-title":"GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology","volume":"43","author":"Chebib","year":"2000","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.00036.2003","article-title":"Molecular structure and physiological functions of GABA(B) receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.011_bb0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-0034-1396012","article-title":"Spasticity and intrathecal baclofen","volume":"34","author":"Furr-Stimming","year":"2014","journal-title":"Semin Neurol"},{"issue":"8","key":"10.1016\/j.autrev.2015.07.011_bb0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.seizure.2013.04.015","article-title":"Molecular mechanisms of antiseizure drug activity at GABAA receptors","volume":"22","author":"Greenfield","year":"2013","journal-title":"Seizure"},{"issue":"24","key":"10.1016\/j.autrev.2015.07.011_bb0120","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.2174\/1381612811319240013","article-title":"Extrasynaptic GABA(A) receptors in the brainstem and spinal cord: structure and function","volume":"19","author":"Delgado-Lezama","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.011_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00726-011-1193-7","article-title":"GABA is an effective immunomodulatory molecule","volume":"45","author":"Jin","year":"2013","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.011_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-5728(98)00264-1","article-title":"GABA(A) receptors mediate inhibition of T cell responses","volume":"96","author":"Tian","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.011_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-1781(01)00220-7","article-title":"Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder","volume":"101","author":"Bjork","year":"2001","journal-title":"Psychiatry Res"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2015.07.011_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jneuroim.2007.05.013","article-title":"GABA (A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6\/IL-12 production","volume":"188","author":"Reyes-Garc\u00eda","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.molimm.2010.08.005","article-title":"Increased GABA(A) channel subunits expression in CD8(+) but not in CD4(+) T cells in BB rats developing diabetes compared to their congenic littermates","volume":"48","author":"Mendu","year":"2011","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0150","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/apha.12467","article-title":"GABAergic signalling in the immune system","volume":"213","author":"Barragan","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"issue":"12","key":"10.1016\/j.autrev.2015.07.011_bb0155","doi-asserted-by":"crossref","first-page":"e1003051","DOI":"10.1371\/journal.ppat.1003051","article-title":"GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii","volume":"8","author":"Fuks","year":"2012","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.011_bb0160","doi-asserted-by":"crossref","first-page":"e17152","DOI":"10.1371\/journal.pone.0017152","article-title":"Anaesthetic impairment of immune function is mediated via GABA(A) receptors","volume":"6","author":"Wheeler","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.autrev.2015.07.011_bb0165","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.4049\/jimmunol.174.11.7242","article-title":"Gamma-amino butyric acid type B receptors stimulate neutrophil chemotaxis during ischemia-reperfusion","volume":"174","author":"Rane","year":"2005","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.011_bb0170","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/TP.0b013e31829c24be","article-title":"GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone","volume":"96","author":"Prud'homme","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2015.07.011_bb0175","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.iy.13.040195.003203","article-title":"Potassium and calcium channels in lymphocytes","volume":"13","author":"Lewis","year":"1995","journal-title":"Annu Rev Immunol"},{"issue":"1\u20133","key":"10.1016\/j.autrev.2015.07.011_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(03)02076-4","article-title":"Modulation of intracellular Cl-homeostasis by lectin-stimulation in Jurkat T lymphocytes","volume":"482","author":"Lai","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0185","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.4049\/jimmunol.159.4.1628","article-title":"Ion channels, Ca2+ signaling, and reporter gene expression in antigen-specific mouse T cells","volume":"159","author":"Kerschbaum","year":"1997","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbrc.2014.08.135","article-title":"GABA protects pancreatic beta cells against apoptosis by increasing SIRT1 expression and activity","volume":"452","author":"Prud'homme","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.autrev.2015.07.011_bb0195","doi-asserted-by":"crossref","first-page":"e46364","DOI":"10.1371\/journal.pone.0046364","article-title":"SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-\u03baB activity","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.07.011_bb0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06826.x","article-title":"The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis","volume":"1281","author":"Padgett","year":"2013","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.autrev.2015.07.011_bb0205","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/intimm\/dxs049","article-title":"Inflammation and type one diabetes","volume":"24","author":"Bending","year":"2012","journal-title":"Int Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0210","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.142.4.1120","article-title":"Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma","volume":"142","author":"Cockfield","year":"1989","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.011_bb0215","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.gt.3300879","article-title":"Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor\/IgG1 fusion protein","volume":"6","author":"Prud'homme","year":"1999","journal-title":"Gene Ther"},{"issue":"42","key":"10.1016\/j.autrev.2015.07.011_bb0220","doi-asserted-by":"crossref","first-page":"16242","DOI":"10.1073\/pnas.0808031105","article-title":"Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice","volume":"105","author":"Koulmanda","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.011_bb0225","doi-asserted-by":"crossref","first-page":"e56924","DOI":"10.1371\/journal.pone.0056924","article-title":"Inhibition of nuclear factor-\u03baB activation in pancreatic \u03b2-cells has a protective effect on allogeneic pancreatic islet graft survival","volume":"8","author":"Eldor","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0230","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1111\/j.1525-1594.2011.01395.x","article-title":"Blockade of the nuclear factor kappa B pathway prolonged islet allograft survival","volume":"36","author":"Ding","year":"2012","journal-title":"Artif Organs"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0235","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2174\/187152811795564046","article-title":"NF-\u03baB in type 1 diabetes","volume":"10","author":"Zhao","year":"2011","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"10","key":"10.1016\/j.autrev.2015.07.011_bb0240","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.20120822","article-title":"Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo","volume":"209","author":"Yadav","year":"2012","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.autrev.2015.07.011_bb0245","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1084\/jem.20120914","article-title":"Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells","volume":"209","author":"Weiss","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.autrev.2015.07.011_bb0250","doi-asserted-by":"crossref","first-page":"e25338","DOI":"10.1371\/journal.pone.0025338","article-title":"Oral treatment with \u03b3-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice","volume":"6","author":"Tian","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.autrev.2015.07.011_bb0255","doi-asserted-by":"crossref","first-page":"e25337","DOI":"10.1371\/journal.pone.0025337","article-title":"Combining antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted \u00df-cells in diabetic NOD mice","volume":"6","author":"Tian","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.07.011_bb0260","first-page":"211","article-title":"Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges","volume":"7","author":"Bruni","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.autrev.2015.07.011_bb0265","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-15-0094","article-title":"Islet transplantation for type 1 diabetes: so close and yet so far away","author":"Khosravi-Maharlooei","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2015.01.005","article-title":"The current challenges for pancreas transplantation for diabetes mellitus","volume":"98","author":"Watson","year":"2015","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.autrev.2015.07.011_bb0275","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.2337\/db14-0153","article-title":"GABA promotes human \u03b2-cell proliferation and modulates glucose homeostasis","volume":"63","author":"Purwana","year":"2014","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.autrev.2015.07.011_bb0280","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3727\/096368909X471198","article-title":"Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets","volume":"18","author":"Johnson","year":"2009","journal-title":"Cell Transplant"},{"key":"10.1016\/j.autrev.2015.07.011_bb0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2015.07.011_bb0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2012.11.001","article-title":"Systemic treatment with the inhibitory neurotransmitter \u03b3-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses","volume":"255","author":"Carmans","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"12","key":"10.1016\/j.autrev.2015.07.011_bb0295","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.4049\/jimmunol.181.12.8226","article-title":"Gamma-aminobutyric acid transporter 1 negatively regulates T cell-mediated immune responses and ameliorates autoimmune inflammation in the CNS","volume":"181","author":"Wang","year":"2008","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.011_bb0300","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4049\/jimmunol.0900767","article-title":"Gamma-aminobutyric acid transporter 1 negatively regulates T cell activation and survival through protein kinase C-dependent signaling pathways","volume":"183","author":"Wang","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2015.07.011_bb0305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/08916934.2011.571223","article-title":"Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis","volume":"44","author":"Tian","year":"2011","journal-title":"Autoimmunity"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.011_bb0310","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jcp.24884","article-title":"The anti-spasticity drug baclofen alleviates collagen-induced arthritis and regulates dendritic cells","volume":"230","author":"Huang","year":"2015","journal-title":"J Cell Physiol"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.011_bb0315","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00403-010-1052-5","article-title":"GABA and GABA(A) receptor expression on immune cells in psoriasis: a pathophysiological role","volume":"302","author":"Nigam","year":"2010","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.autrev.2015.07.011_bb0320","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/0128071-200809060-00012","article-title":"Improvement in psoriasis following treatment with gabapentin and pregabalin","volume":"9","author":"Boyd","year":"2008","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.011_bb0325","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1600-0625.2010.01076.x","article-title":"Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis","volume":"19","author":"Duthey","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0330","article-title":"Stiff-person syndrome: insights into a complex autoimmune disorder","author":"Baizabal-Carvallo","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.011_bb0335","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0033-1334477","article-title":"Stiff person syndrome and other anti-GAD-associated neurologic disorders","volume":"32","author":"Dayalu","year":"2012","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0340","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410440209","article-title":"Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome","volume":"44","author":"Dinkel","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0345","doi-asserted-by":"crossref","first-page":"11196","DOI":"10.1038\/srep11196","article-title":"Elevated serum GAD65 and GAD65-GADA immune complexes in stiff person syndrome","volume":"5","author":"Gu Urban","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2015.07.011_bb0350","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnbeh.2015.00078","article-title":"Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions","volume":"9","author":"Manto","year":"2015","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0355","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00702-014-1268-1","article-title":"Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms","volume":"122","author":"Werner","year":"2015","journal-title":"J Neural Transm"},{"issue":"9","key":"10.1016\/j.autrev.2015.07.011_bb0360","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jamaneurol.2013.3499","article-title":"Neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome","volume":"70","author":"Chang","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0365","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.expneurol.2012.10.013","article-title":"Human stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats","volume":"239","author":"Hansen","year":"2013","journal-title":"Exp Neurol"},{"issue":"11","key":"10.1016\/j.autrev.2015.07.011_bb0370","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/1744666X.2013.845527","article-title":"Immunology of stiff person syndrome and other GAD-associated neurological disorders","volume":"9","author":"Alexopoulos","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0375","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.011_bb0380","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrendo.2012.237","article-title":"Immune therapy in type 1 diabetes mellitus","volume":"9","author":"Lernmark","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0385","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/brain\/awl245","article-title":"Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome","volume":"129","author":"Raju","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2015.07.011_bb0390","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/cei.12026","article-title":"Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals","volume":"171","author":"Ch\u00e9ramy","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0395","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4049\/jimmunol.156.2.818","article-title":"Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition","volume":"156","author":"Daw","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0400","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.178.6.2097","article-title":"Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome","volume":"178","author":"Butler","year":"1993","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2015.07.011_bb0405","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08830180701883240","article-title":"Immunobiology of stiff-person syndrome","volume":"27","author":"Raju","year":"2008","journal-title":"Int Rev Immunol"},{"issue":"24","key":"10.1016\/j.autrev.2015.07.011_bb0410","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.011_bb0415","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2015.07.011_bb0420","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ana.410090516","article-title":"Baclofen in the treatment of stiff-man syndrome","volume":"9","author":"Miller","year":"1981","journal-title":"Ann Neurol"},{"issue":"23","key":"10.1016\/j.autrev.2015.07.011_bb0425","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1097\/MD.0000000000000954","article-title":"A case of stiff person syndrome: immunomodulatory effect of benzodiazepines: successful rituximab and tizanidine therapy","volume":"94","author":"Zdziarski","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0430","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0035-1552625","article-title":"Autoimmune epilepsy","volume":"35","author":"Toledano","year":"2015","journal-title":"Semin Neurol"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0435","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1684\/epd.2014.0702","article-title":"Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier","volume":"16","author":"Hainsworth","year":"2014","journal-title":"Epileptic Disord"},{"issue":"10","key":"10.1016\/j.autrev.2015.07.011_bb0440","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/14737175.2014.956457","article-title":"Autoimmunity and inflammation in status epilepticus: from concepts to therapies","volume":"14","author":"Holzer","year":"2014","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.011_bb0445","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/dmcn.12647","article-title":"The recognition and treatment of autoimmune epilepsy in children","volume":"57","author":"Suleiman","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0450","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1684\/epd.2014.0703","article-title":"Effectiveness of multimodality treatment for autoimmune limbic epilepsy","volume":"16","author":"Dubey","year":"2014","journal-title":"Epileptic Disord"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.011_bb0455","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2217\/imt.13.172","article-title":"Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives","volume":"6","author":"Wan","year":"2014","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0460","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4239\/wjd.v6.i3.380","article-title":"Type 1 diabetes: a predictable disease","volume":"6","author":"Simmons","year":"2015","journal-title":"World J Diabetes"},{"issue":"8","key":"10.1016\/j.autrev.2015.07.011_bb0465","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007658","article-title":"Islet autoantigens: structure, function, localization, and regulation","volume":"2","author":"Arvan","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0470","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/092986711794480230","article-title":"Peptide immunotherapies in type 1 diabetes: lessons from animal models","volume":"18","author":"Fierabracci","year":"2011","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0475","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2217\/imt.11.9","article-title":"GAD-alum immunotherapy in type 1 diabetes mellitus","volume":"3","author":"Morales","year":"2011","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0480","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/dmrr.941","article-title":"Therapy with GAD in diabetes","volume":"25","author":"Ludvigsson","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.011_bb0485","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clim.2010.10.004","article-title":"GAD-alum treatment induces GAD65-specific CD4+ CD25highFOXP3+ cells in type 1 diabetic patients","volume":"138","author":"Hjorth","year":"2011","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.011_bb0490","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1107096","article-title":"GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus","volume":"366","author":"Ludvigsson","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.011_bb0495","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ymthe.2006.03.021","article-title":"Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand","volume":"14","author":"Glinka","year":"2006","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.011_bb0500","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.gt.3302907","article-title":"Plasmid-based gene therapy of diabetes mellitus","volume":"14","author":"Prud'homme","year":"2007","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.011_bb0505","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clim.2008.06.001","article-title":"Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice","volume":"129","author":"Goudy","year":"2008","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.011_bb0510","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/07853890008995930","article-title":"DNA vaccination to treat autoimmune diabetes","volume":"32","author":"von Herrath","year":"2000","journal-title":"Ann Med"},{"issue":"12","key":"10.1016\/j.autrev.2015.07.011_bb0515","first-page":"1111","article-title":"Rodent islet cell antigens recognized by antibodies in sera from diabetic patients","volume":"41","author":"Baekkeskov","year":"1982","journal-title":"Acta Biol Med Ger"},{"issue":"6450","key":"10.1016\/j.autrev.2015.07.011_bb0520","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/366072a0","article-title":"Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice","volume":"366","author":"Tisch","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2015.07.011_bb0525","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.05.002","article-title":"The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes","volume":"44","author":"Boettler","year":"2013","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.011_bb0530","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-2007-978750","article-title":"Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice","volume":"31","author":"Kash","year":"1999","journal-title":"Horm Metab Res"},{"issue":"12","key":"10.1016\/j.autrev.2015.07.011_bb0535","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/diabetes.47.12.1848","article-title":"Differential protection in two transgenic lines of NOD\/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells","volume":"47","author":"Bridgett","year":"1998","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.autrev.2015.07.011_bb0540","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.2337\/db13-1385","article-title":"Combined therapy with GABA and proinsulin\/alum acts synergistically to restore long-term normoglycemia by modulating T-cell autoimmunity and promoting \u03b2-cell replication in newly diabetic NOD mice","volume":"63","author":"Tian","year":"2014","journal-title":"Diabetes"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2015.07.011_bb0550","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1528-1167.2011.03035.x","article-title":"Antiepileptic drugs and the immune system","volume":"52","author":"Beghi","year":"2011","journal-title":"Epilepsia"},{"issue":"1\u20133","key":"10.1016\/j.autrev.2015.07.011_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.01.007","article-title":"Propofol: a review of its non-anaesthetic effects","volume":"605","author":"Vasileiou","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.011_bb0560","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0163-7258(97)00055-7","article-title":"Benzodiazepines, anxiety and immunity","volume":"75","author":"Zavala","year":"1997","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.011_bb0565","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1060028013510698","article-title":"Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients","volume":"48","author":"Smith","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"5 Pt 2","key":"10.1016\/j.autrev.2015.07.011_bb0570","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1592\/phco.2005.25.5_Part_2.28S","article-title":"Propofol: an immunomodulating agent","volume":"25","author":"Marik","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.autrev.2015.07.011_bb0575","series-title":"Inhibition in the Nervous System and Gamma-Aminobutyric Acid","first-page":"562","article-title":"The administration of gamma-aminobutyric acid to man: systemic effects and anticonvulsant actions","author":"Tower","year":"1960"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.011_bb0580","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0026-0495(82)90029-4","article-title":"Effects of gamma aminobutyric acid (GABA) and muscimol on endocrine pancreatic function in man","volume":"31","author":"Cavagnini","year":"1982","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.011_bb0585","first-page":"3","article-title":"On the role of gamma aminobutyric acid in the regulation of the level of glycemia in diabetes mellitus","volume":"7","author":"Khumarian","year":"1967","journal-title":"Zh Eksp Klin Med"},{"key":"10.1016\/j.autrev.2015.07.011_bb0590","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000341944","article-title":"GABA supplementation and growth hormone response","volume":"59","author":"Powers","year":"2012","journal-title":"Med Sport Sci"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.011_bb0595","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1249\/mss.0b013e318158b518","article-title":"Growth hormone isoform responses to GABA ingestion at rest and after exercise","volume":"40","author":"Powers","year":"2008","journal-title":"Med Sci Sports Exerc"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T12:51:45Z","timestamp":1691844705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997215001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":118,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1568997215001603"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.07.011","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological GABAergic interactions and therapeutic applications in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}